Wave Life Sciences Ltd’s recently made public that its 10% Owner GSK plc acquired Company’s shares for reported $27.93 million on Dec 11 ’25. In the deal valued at $19.00 per share,1,470,000 shares were bought. As a result of this transaction, GSK plc now holds 18,245,691 shares worth roughly $293.94 million.
Then, Rawcliffe Adrian sold 42,000 shares, generating $630,000 in total proceeds. Upon selling the shares at $15.00, the Director now owns 12,700 shares.
Before that, Wagner Heidi L sold 14,000 shares. Wave Life Sciences Ltd shares valued at $189,000 were divested by the Director at a price of $13.50 per share. As a result of the transaction, Wagner Heidi L now holds 44,930 shares, worth roughly $0.72 million.
Wedbush reiterated its Wave Life Sciences Ltd [WVE] rating to an Outperform in a research note published on December 12, 2025; the price target was $33. A number of analysts have revised their coverage, including RBC Capital Mkts’s analysts, who increased its forecast for the stock in early December from “a Sector perform” to “an Outperform”. Wells Fargo began covering WVE with “an Overweight” recommendation on October 20, 2025. Canaccord Genuity started covering the stock on August 04, 2025. It rated WVE as “a Buy”.
Price Performance Review of WVE
On Monday, Wave Life Sciences Ltd [NASDAQ:WVE] saw its stock fall -2.72% to $16.11. Over the last five days, the stock has lost -13.01%. Wave Life Sciences Ltd shares have risen nearly 4.54% since the year began. Nevertheless, the stocks have risen 30.23% over the past one year. While a 52-week high of $21.73 was reached on 12/09/25, a 52-week low of $5.28 was recorded on 04/09/25.
Levels Of Support And Resistance For WVE Stock
The 24-hour chart illustrates a support level at 15.70, which if violated will result in even more drops to 15.28. On the upside, there is a resistance level at 16.80. A further resistance level may holdings at 17.49.
How much short interest is there in Wave Life Sciences Ltd?
A steep rise in short interest was recorded in Wave Life Sciences Ltd stocks on 2025-11-28, growing by 2.66 million shares to a total of 16.03 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-31 was 13.37 million shares. There was a rise of 16.6%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on July 28, 2025 when Oppenheimer began covering the stock and recommended ‘”an Outperform”‘ rating along with a $24 price target.
